Company Announcements

Director/PDMR Shareholding

Source: RNS
RNS Number : 5409W
Rentokil Initial PLC
22 December 2021
 

Rentokil Initial plc (the "Company")

22 December 2021

 

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

The Company hereby announces that John Myers, Managing Director, North America, purchased 10,000 ordinary shares in the Company at a price of US$7.7592 per share on 21 December 2021.

 

The notification set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

John Myers

2

 

Reason for the notification

 

a)

 

Position/status

 

Managing Director, North America (PDMR)

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

US$7.7592

 

10,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Aggregated price

 

- Total

 

 

 

10,000

 

US$7.7592

 

US$77,592.00

e)

 

Date of the transaction

 

21 December 2021

f)

 

Place of the transaction

 

US (OTC)

 

 

Enquiries:

 

Daragh Fagan, Company Secretary     Rentokil Initial plc              01276 607444

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLBDDBDDDGBD